NewGenIvf Group Limited Price & Performance (NIVF)

NewGenIvf Group has achieved a remarkable financial recovery, moving from a $7 million deficit to a $10 million surplus in just five months. This turnaround coincides with the completion of its MicroSort Reproductive Technology acquisition. Meanwhile, uncertainties loom over its proposed reverse merger with European Wellness Holdings due to unmet conditions.12

NewGenIvf has regained compliance with Nasdaq's listing requirements following a reverse stock split and a transfer to the Nasdaq Capital Market. Additionally, the company is diversifying with a $1 million cryptocurrency investment, signaling efforts to stabilize financials and explore new revenue streams amid stock price challenges.34

NewGenIvf is launching a lifetime egg freezing service targeting affluent women in Asia, a move expected to generate up to $36.4 million in profits within five years. Led by Thorain Ko, this initiative aims to address regional restrictions and expand the company’s customer base by 10% over the same period.56